Want to learn more? Check out our

Dural Venous Sinus Stenosis

February 6, 2023

Dural Venous Sinus Stenosis with Visish M. Srinivasan, MD moderated by Gary R. Duckwiler, MD.

Disclaimer: As of this webinar, no stent has been approved by the FDA for use in the venous sinuses of the brain. Therefore, venous sinus stenting is currently performed with stents used off-label. Neither IIH-Hub nor Serenity Medical, Inc. endorse the off-label usage of stents. The views expressed in this video are those of the speakers alone.

Visish Srinivasan, MD, Speaker Idiopathic-Intracranial Hypertension-(IIH) Practioner Webinar Series

Visish M. Srinivasan, MD

Assistant Professor of Neurosurgery at the Hospital of the University of Pennsylvania

Dr. Srinivasan is a comprehensive cerebrovascular neurosurgeon, with advanced training in both microsurgical/skull base techniques as well as endovascular techniques to treat cerebrovascular disorders. This includes aneurysms, arteriovenous malformations (AVMs), arteriovenous fistulas, cavernous malformations, ischemic stroke, intracranial hemorrhage, subarachnoid hemorrhage, moyamoya disease, and carotid disease.

Gary Duckwiler MD, Moderator Idiopathic-Intracrania Hypertension-(IIH) Practioner Webinar Series

Gary R. Duckwiler, MD

Director and Professor of the Division of Interventional Neuroradiology at UCLA Medical Center

Dr. Gary R. Duckwiler is a Professor at the University of California, Los Angeles. He is the Chief and Co-Director of the HHT (Hereditary Hemorrhagic Telangiectasia) Center of Excellence at the David Geffen School of Medicine at UCLA, and Co-Founder of the UCLA Vascular Birthmark Center.

Idiopathic Intracranial Hypertension (IIH) is an underdiagnosed and undertreated disorder of elevated pressure within the brain without an identifiable cause. The IIH Practioner Series is designed for neurologists, neurosurgeons, neuro-interventionalists, endovascular surgeons, interventionist radiologists, neuroradiologists, ophthalmologists, optometrists, and ENT specialists.

Sponsored by

Novel neurovascular therapies for idiopathic intracranial hypertension (IIH)

Like what you are seeing?

Join our next webinar.

Thank you! You’re registration is complete for:

IIH Community Chat

Discussion on navigating through the healthcare system

Coming in April